where is the best injection site for glp 1 & WORST Sites GLP1 Weight Loss: Does it matter? Where to inject for MAXIMUM

Some newer drugs combine GLP-1 receptor agonists with other metabolic targets or additional mechanisms to achieve more effective weight loss

PMID: 77 OlaniyiKSBashirAMAreloegbeSESabinariIWAkintayoCOOniyideAAet al

Remember, youre not alone in this

Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications

95% CI, 4.13 to 214.2

Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence